The Future of Obesity Care: Exploring Synergies Between Metabolic Bariatric Surgery, Interventional Endoscopy and Pharmacotherapy

1

The approval of semaglutide and tirzepatide represents significant advancements in pharmacological obesity management.
2

Combining obesity management medications with metabolic bariatric surgery may enhance treatment outcomes for obesity.
3

The IFSO consensus statement emphasizes the need for further research on the integration of obesity therapies.
4

Limited randomized controlled trials have explored the efficacy of combining obesity medications with bariatric surgery.
5

Key research themes include patient acceptability, long-term efficacy, and optimal dosing of combined obesity therapies.

Obesity Surgery

by Wendy A. Brown, Priya Sumithran, Michael Cowley, Ricardo Cohen, Carel Le Roux, Philip Schauer, Santosh Agarwal, Jamie Ard, Camilo Boza, Jenny Lynn Cargiuolo, Letizia Ceccarelli, Jake Coverdale, Brian Dunkin, Francis Finucane, Kapil Gupta, Lee M. Kaplan, Marina Kurian, Ildiko Lingvay, Alex Miras, Chuck Pearlman, Terissa Petry, Dimitri Pournaras, Jonthan Purnell, Roxana Ruiz, Carlos Schiavon, Abd Tahrani, Hanan Tarek, Jorg Tomaszewski, Sascha Tumik, Ramy Younes
May 4, 2026

1